Alpha Quant Advisors’s Amedisys AMED Stock Holding History

Alpha Quant Advisors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$29K	Buy	237 +137	+137%	+$17.2K	0.03%	137
2018 Q4	$12K	Buy	+100	New	+$11.8K	0.01%	232

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Alpha Quant Advisors's AMED Position: Q1 2019 in Review

Alpha Quant Advisors increased its Amedisys (AMED) stake by 137% in Q1 2019, buying an estimated $17.2K and bringing the position to 237 shares worth $29K. The position accounts for 0.03% of the portfolio, ranked #137.

Alpha Quant Advisors first reported a position in AMED in Q4 2018 and has held it in 2 quarters since. 317 funds tracked by Wall St. Rank hold AMED as of Q1 2019.

Alpha Quant Advisors held 237 shares of Amedisys worth $29K as of Q1 2019.
Alpha Quant Advisors bought 137 Amedisys shares in Q1 2019, an estimated $17.2K.
Amedisys made up 0.03% of Alpha Quant Advisors's portfolio in Q1 2019, its #137 holding.
Alpha Quant Advisors first reported a position in Amedisys in Q4 2018 and has held it in 2 quarters since.
317 funds tracked by Wall St. Rank held Amedisys as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.